Atlas Trials

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Clinical trial NCT00898430 · TERMINATED

Trial details

NCT number
NCT00898430
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
Head and Neck Cancer
Start date
2003-11-01
Primary completion
2011-02-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.